John Mendlein - Director, Atyr Pharma Inc

As of May 10, 2019


John Mendlein Net Worth

  • Net worth is estimated to be at least $12.18M
  • Owns at least 615,382 units of Atyr Pharma Inc stock

John Mendlein Trading

  • Largest purchase of shares was 69,000 units , worth over $151.66K on December 21, 2016
  • In total has made about 13 transactions over 4 years
  • Usually trades in May, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Atyr Pharma Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Sanjay S. Shukla, M.D., M.S. 2020 $470,250 $223,369 $381,811 $223,369 $8,427 $1,083,857
Sanjay S. Shukla, M.D., M.S. 2019 $450,000 $95,625 $82,400 $95,625 $10,076 $663,961
Jill M. Broadfoot 2020 $365,750 $138,985 $182,671 $138,985 $11,374 $698,780
Jill M. Broadfoot 2019 $350,000 $59,500 $20,600 $59,500 $11,594 $454,624
Nancy E. Denyes 2020 $350,075 $116,400 $148,121 $116,400 $10,661 $625,257
Nancy E. Denyes 2019 $335,000 $49,831 $51,500 $49,831 $12,932 $449,263
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1339970/000156459021014935/life-def14a_20210428.htm

Atyr Pharma Inc Insider Trading

  • The most recent transaction was 2,500 units sold on May 25, 2021 by John Clarke worth over $10.85K
  • In the last 6 years, insiders at Atyr Pharma Inc sold an estimated value of $3.13M and bought an estimated value of $14.37M
  • The most active traders are Paul Schimmel, Director,  John Mendlein, Director,  and Sanjay Shukla, President and CEO
  • Insider trading is most common in May, with the busiest year in 2016

aTYR PHARMA INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1